ReviewJournal of gastrointestinal cancer2025

Neoadjuvant Pembrolizumab Enables Successful Downstaging and Resection of Borderline Resectable MSI-H/dMMR Pancreatic Ductal Adenocarcinoma: A Case Report and Literature Review.

Kevin Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.